I’m delighted to say we have secured some great speakers for this webinar, which is the latest in a series we have been hosting in association with Lecorpio.
The webinar takes place this Thursday September 24 at 6pm (London), 1pm (New York), 10 am (West Coast).
Joining me for the discussion will be:
Fran Jagla (right), a shareholder of Lane Powell, who has spent much of her career in house at companies such as Abbott Laboratories and Microsoft and has extensive experience in name development, clearance filing, registration, maintenance and enforcement of trade marks and copyrights.
Jeff Epstein (below left), a partner of Cowan Liebowitz & Latman, who practises in trade mark and copyright law, including before the TTAB and advises many multinational companies on their worldwide IP protection strategies.
Mark Bullard (below right), who will be familiar to those of you who have listened to previous webinars in this series and is vice president of product management at Lecorpio.
The discussion, which promises to be open and frank, will focus on the pros and cons of the Madrid System, particularly as it grows in the Americas (Mexico and Colombia have recently joined, and Canada is expected to do so soon).
It is particularly aimed at trade mark practitioners in the US who use, or are considering using, Madrid for their trade mark portfolios. But we anticipate that it will also be of interest to practitioners in other countries.
We plan to debate advantages such as the cost, speed and simplicity of the system as well as challenges related to the specification of goods, bona fide intent to use, limitations and central attack.
We will also be discussion the experience so far in the US, Mexico, Colombia, Cuba and Antigua & Barbuda, as well as the possibility of Brazil and Canada joining, and what impact that would have.
Finally, we will look at some specific issues in the pharmaceutical, fashion and motion picture industries.
As with all our webinars, there will also be an opportunity for the audience to ask questions of the panellists.
The webinar is free to attend: just register here and join us on Thursday.
